CN116969916A - 一种制备5-氨基乙酰丙酸盐酸盐的方法 - Google Patents
一种制备5-氨基乙酰丙酸盐酸盐的方法 Download PDFInfo
- Publication number
- CN116969916A CN116969916A CN202310841671.XA CN202310841671A CN116969916A CN 116969916 A CN116969916 A CN 116969916A CN 202310841671 A CN202310841671 A CN 202310841671A CN 116969916 A CN116969916 A CN 116969916A
- Authority
- CN
- China
- Prior art keywords
- formula
- diethyl
- ethyl
- acid
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 30
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 title claims abstract description 23
- 229950010481 5-aminolevulinic acid hydrochloride Drugs 0.000 title claims abstract description 10
- OHLRLMWUFVDREV-UHFFFAOYSA-N ethyl 4-chloro-3-oxobutanoate Chemical compound CCOC(=O)CC(=O)CCl OHLRLMWUFVDREV-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000004519 manufacturing process Methods 0.000 claims abstract description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 29
- 238000006243 chemical reaction Methods 0.000 claims description 23
- -1 ethyl 4- (2, 2-dimethyl-4, 6-dioxo-1, 3-dioxane-5-yl) -3-oxobutyrate Chemical compound 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 7
- ONRIYMIXCUUSNS-UHFFFAOYSA-N diethyl 3-oxohexanedioate Chemical compound CCOC(=O)CCC(=O)CC(=O)OCC ONRIYMIXCUUSNS-UHFFFAOYSA-N 0.000 claims description 7
- GXHFUVWIGNLZSC-UHFFFAOYSA-N meldrum's acid Chemical compound CC1(C)OC(=O)CC(=O)O1 GXHFUVWIGNLZSC-UHFFFAOYSA-N 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- ZFUSMIDQQIAJKY-UHFFFAOYSA-N diethyl 2-hydroxyimino-3-oxohexanedioate Chemical compound CCOC(=O)CCC(=O)C(=NO)C(=O)OCC ZFUSMIDQQIAJKY-UHFFFAOYSA-N 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 235000010288 sodium nitrite Nutrition 0.000 claims description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 3
- 229960000583 acetic acid Drugs 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000007789 gas Substances 0.000 claims description 3
- 239000012362 glacial acetic acid Substances 0.000 claims description 3
- 238000001953 recrystallisation Methods 0.000 claims description 3
- 238000006722 reduction reaction Methods 0.000 claims description 3
- 239000001632 sodium acetate Substances 0.000 claims description 3
- 235000017281 sodium acetate Nutrition 0.000 claims description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 3
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 230000009935 nitrosation Effects 0.000 claims description 2
- 238000007034 nitrosation reaction Methods 0.000 claims description 2
- FYRHIOVKTDQVFC-UHFFFAOYSA-M potassium phthalimide Chemical compound [K+].C1=CC=C2C(=O)[N-]C(=O)C2=C1 FYRHIOVKTDQVFC-UHFFFAOYSA-M 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- 239000002994 raw material Substances 0.000 abstract description 7
- 238000009776 industrial production Methods 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 229960002749 aminolevulinic acid Drugs 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 10
- JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 229940040102 levulinic acid Drugs 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000000967 suction filtration Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- QIAFMBKCNZACKA-UHFFFAOYSA-N N-benzoylglycine Chemical compound OC(=O)CNC(=O)C1=CC=CC=C1 QIAFMBKCNZACKA-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000004176 ammonification Methods 0.000 description 2
- 230000031709 bromination Effects 0.000 description 2
- 238000005893 bromination reaction Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- LRSVGRBPVQKHQT-UHFFFAOYSA-N diethyl 2-oxohexanedioate Chemical compound CCOC(=O)CCCC(=O)C(=O)OCC LRSVGRBPVQKHQT-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000002363 herbicidal effect Effects 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- RINCXYDBBGOEEQ-UHFFFAOYSA-N succinic anhydride Chemical class O=C1CCC(=O)O1 RINCXYDBBGOEEQ-UHFFFAOYSA-N 0.000 description 2
- KZEVSDGEBAJOTK-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[5-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CC=1OC(=NN=1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O KZEVSDGEBAJOTK-UHFFFAOYSA-N 0.000 description 1
- IHCCLXNEEPMSIO-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 IHCCLXNEEPMSIO-UHFFFAOYSA-N 0.000 description 1
- JVKRKMWZYMKVTQ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JVKRKMWZYMKVTQ-UHFFFAOYSA-N 0.000 description 1
- DFGKGUXTPFWHIX-UHFFFAOYSA-N 6-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]acetyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)C1=CC2=C(NC(O2)=O)C=C1 DFGKGUXTPFWHIX-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960000781 aminolevulinic acid hydrochloride Drugs 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000006146 oximation reaction Methods 0.000 description 1
- YNOGYQAEJGADFJ-UHFFFAOYSA-N oxolan-2-ylmethanamine Chemical compound NCC1CCCO1 YNOGYQAEJGADFJ-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000007539 photo-oxidation reaction Methods 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/04—Formation of amino groups in compounds containing carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
- C07C249/10—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes from nitro compounds or salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/03—Preparation of carboxylic acid esters by reacting an ester group with a hydroxy group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/317—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
- C07C67/32—Decarboxylation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明提供了一种以4‑氯乙酰乙酸乙酯为原料制备5‑氨基乙酰丙酸盐酸盐的方法,该方法操作简单,生产成本低,收率高,非常适合工业化生产。
Description
技术领域
本发明属于有机合成技术领域,具体涉及一种制备5-氨基乙酰丙酸盐酸盐的方法。
背景技术
5-氨基乙酰丙酸(5-ALA)是一种广泛存在于植物与动物细胞中的天然氨基酸,是皮肤癌的诊断剂,及化妆品的原料,用于美白效果明显。在医学方面,5-ALA具有能够选择性杀伤癌细胞的作用,可应用于癌症的治疗,被称为第二代光动力药物。因其具有无毒、环保、在自然环境中极易降解、无任何残留等显著优点,作为一类环境友好、选择性高的广谱除草剂和杀虫剂,在农业领域也被广泛应用。因此,5-ALA是一种具有广阔应用前景的化学物质。
现有技术公开的 5-ALA的制备方法主要有生物发酵法和化学合成法。生物发酵法虽然具有对环境友好,原料易得等优点,但因其反应时间长,反应条件苛刻,收率低等缺点,使得该方法的成本较高。化学合成法的研究始于上世纪50年代,研究者们以马尿酸、丁二酸酐衍生物、吡啶衍生物、乙酰丙酸、甘氨酸等为原料合成5-ALA。Audelaman等人以丁二酸酐衍生物为原料,通过肟化、加氢还原水解等步骤合成5-ALA。Kawakami等人以四氢糠胺为原料,通过氨化、氧化、 酸解三步合成5-ALA。刘宗章等人以乙酰丙酸为原料,通过溴代、氨化、酸解等步骤合成5-ALA。2011年,Mascal等人提出以纤维素或葡萄糖为原料经浓盐酸催化合成5-CMF,然后经叠氮化、光氧化、催化还原等步骤得到5-ALA。此方法具有原料和试剂廉价的优点,但该反应过程较危险、反应条件苛刻。
目前,现有技术公开的合成5-ALA的方法普遍存在反应步骤多,操作繁琐,收率低,反应条件苛刻,危险性高等技术问题,因此,寻找一种操作简便,生产成本低,收率高的5-ALA制备方法是极具意义的。
发明内容
本发明的目的在于克服现有技术的不足之处,提供了一种制备5-氨基乙酰丙酸盐酸盐的方法,解决了上述背景技术中存在的技术问题。
因此,本发明提供了一种制备5-氨基乙酰丙酸盐酸盐的方法,所述方法包括:
步骤(一):
使式(2)所示的4-氯乙酰乙酸乙酯在适当的溶剂中,在碱存在下与式(3)所示的丙二酸亚异丙酯进行反应,得到式(4)所示的4-(2,2-二甲基-4,6-二氧代-1,3-二氧六环-5-基)-3-氧代丁酸乙酯。
其中,式(2)所示的4-氯乙酰乙酸乙酯与式(3)所示的丙二酸亚异丙酯的摩尔比为0.1~2:1。
其中,所述溶剂选自N,N-二甲基甲酰胺(DMF),四氢呋喃或者丙酮,所述碱选自氢氧化钠,氢氧化钾,醋酸钠或邻苯二甲酰亚胺钾。
步骤(二):
使式(4)所示的4-(2,2-二甲基-4,6-二氧代-1,3-二氧六环-5-基)-3-氧代丁酸乙酯在乙醇中,在酸存在下进行回流反应,得到式(5)所示的3-氧代己二酸二乙酯。其中,所述酸选自5%的浓硫酸,或者无水氯化氢气体。
步骤(三):
使式(5)所示的3-氧代己二酸二乙酯在冰醋酸中与亚硝酸钠进行亚硝化反应,得到式(6)所示的2-(羟基亚氨基)-3-氧代己二酸二乙酯。
步骤(四):
使式(6)所示的2-(羟基亚氨基)-3-氧代己二酸二乙酯在适当的溶剂中,经还原反应得到式(7)所示的2-氨基-3-氧代己二酸二乙酯。
其中,所述还原反应在10-60℃温度下,在Pd/C存在下通入氢气进行反应,所述溶剂选自无水乙醇。
步骤(五):
使式(7)所示的2-氨基-3-氧代己二酸二乙酯在2-12mol/L的盐酸中加热回流反应4-24小时,反应结束后,将反应液浓缩至干,接着向浓缩物中加入丙酮进行重结晶,得到式(1)所示的5-氨基乙酰丙酸盐酸盐。
本发明的技术方案与现有技术相比,具有如下优点:
1.本发明工艺路线避免了以乙酰丙酸溴代带来的高成本,高危险等问题;
2.本发明工艺路线避免使用叠氮化钠带来的高危险,实验操作条件苛刻等问题;
3.本发明选用的原料来源广泛,廉价易得;反应条件温和,反应产率和选择性高,有着很好的工业应用前景。
实施方式
以下通过实施例对本发明进行详细说明,必须指出,这些实施例是用于说明本发明,而不是对本发明的限制。
实施例1 4-(2,2-二甲基-4,6-二氧代-1,3-二氧六环-5-基)-3-氧代丁酸乙酯的制备
将16.4g 4-氯乙酰乙酸乙酯在室温下溶于200mL 丙酮中,置于圆底烧瓶中混合均匀,加入氢氧化钠(4.2g),冷却至0℃后,分批加入丙二酸亚异丙酯,加完后自然升至室温反应过夜;反应完毕后,减压浓缩掉丙酮,剩余物倒入200ml水中,搅拌下析出固体4-(2,2-二甲基-4,6-二氧代-1,3-二氧六环-5-基)-3-氧代丁酸乙酯(25g);收率96%。
实施例2 4-(2,2-二甲基-4,6-二氧代-1,3-二氧六环-5-基)-3-氧代丁酸乙酯的制备
将16.4g 4-氯乙酰乙酸乙酯在室温下溶于200mL 丙酮中,置于圆底烧瓶中混合均匀,加入醋酸钠(5.2g),冷却至0℃后,分批加入丙二酸亚异丙酯,加完后自然升至室温反应过夜;反应完毕后,减压浓缩掉丙酮,剩余物倒入200ml水中,搅拌下析出固体4-(2,2-二甲基-4,6-二氧代-1,3-二氧六环-5-基)-3-氧代丁酸乙酯(24g),产率95%。
实施例3 4-(2,2-二甲基-4,6-二氧代-1,3-二氧六环-5-基)-3-氧代丁酸乙酯的制备
将16.4g 4-氯乙酰乙酸乙酯在室温下溶于200mL 丙酮中,置于圆底烧瓶中混合均匀,无水碳酸钠钠(8.2g),冷却至0℃后,分批加入丙二酸亚异丙酯,加完后自然升至室温反应过夜;反应完毕后,减压浓缩掉丙酮,剩余物倒入200ml水中,搅拌下析出固体4-(2,2-二甲基-4,6-二氧代-1,3-二氧六环-5-基)-3-氧代丁酸乙酯(26g),产率(98%)。
实施例4 3-氧代己二酸二乙酯的制备
将100g 4-(2,2-二甲基-4,6-二氧代-1,3-二氧六环-5-基)-3-氧代丁酸乙酯溶于600ml无水乙醇中,室温下缓慢加入5%的浓硫酸(10g),升温至回流过夜。反应完毕后,减压浓缩掉乙醇,剩余物倒入120ml饱和碳酸氢钠溶液中,加入乙酸乙酯(2X200ml)萃取,合并乙酸乙酯层,加入无水硫酸钠干燥,减压浓缩至干得到3-氧代己二酸二乙酯(85g),产率92%。
实施例5 3-氧代己二酸二乙酯的制备
将100g 4-(2,2-二甲基-4,6-二氧代-1,3-二氧六环-5-基)-3-氧代丁酸乙酯溶于600ml无水乙醇中,室温下慢慢通入氯化氢气体,然后升温至回流过夜;反应完毕后,减压浓缩掉乙醇,剩余物倒入120ml饱和碳酸氢钠溶液中,加入乙酸乙酯(2X200ml)萃取,合并乙酸乙酯层,加入无水硫酸钠干燥,减压浓缩至干得到3-氧代己二酸二乙酯(88g),产率95%。
实施例6 2-(羟基亚氨基)-3-氧代己二酸二乙酯的制备
将3-氧代己二酸二乙酯(21.6g)溶于216ml冰醋酸中,冷却至0℃,搅拌下慢慢滴入亚硝酸钠的水溶液(8.8g亚硝酸钠溶于20ml水中),滴完后自然升温至室温,反应过夜。反应完毕,将反应液倒入1升冰水中,搅拌下析出固体,抽滤,收集固体得到2-(羟基亚氨基)-3-氧代己二酸二乙酯(20.5g),产率88%。
实施例7 2-氨基-3-氧代己二酸二乙酯的制备
将2-(羟基亚氨基)-3-氧代己二酸二乙酯(245.0g)溶于1.5升的无水乙醇中,室温下加入24.5g钯碳(10%),常压下通入氢气,反应24小时后,抽滤,回收钯碳(循环使用),滤液减压浓缩得到2-氨基-3-氧代己二酸二乙酯(油状物)。
实施例8 2-氨基-3-氧代己二酸二乙酯的制备
将2-(羟基亚氨基)-3-氧代己二酸二乙酯(245.0g)溶于1.5升的无水乙醇中,室温下加入24.5g钯碳(10%),加入醋酐(1.2eq),常压下通入氢气,反应24小时后,抽滤,回收钯碳(循环使用),滤液减压浓缩得中间体7(油状物)。
实施例9 5-氨基乙酰丙酸盐酸盐的制备
将2-氨基-3-氧代己二酸二乙酯(23.1g),50mL 6mol/L的盐酸置于圆底烧瓶中,在温度为110℃下反应8h,反应结束后,将反应液减压浓缩至干,接着向浓缩物中加入乙醇进行重结晶,得到5-氨基乙酰丙酸盐酸盐的白色晶体颗粒(14.7g),产率为77.3%。
Claims (9)
1.一种制备5-氨基乙酰丙酸盐酸盐的方法,其特征在于,所述方法包括:
步骤(一):
使式(2)所示的4-氯乙酰乙酸乙酯在适当的溶剂中,在碱存在下与式(3)所示的丙二酸亚异丙酯进行反应,得到式(4)所示的4-(2,2-二甲基-4,6-二氧代-1,3-二氧六环-5-基)-3-氧代丁酸乙酯。
2.根据权利要求1所述的方法,其特征在于,所述溶剂选自N,N-二甲基甲酰胺,四氢呋喃或者丙酮,所述碱选自氢氧化钠,氢氧化钾,醋酸钠或邻苯二甲酰亚胺钾。
3.根据权利要求1或2所述的方法,其特征在于,式(2)所示的4-氯乙酰乙酸乙酯与式(3)所示的丙二酸亚异丙酯的摩尔比为0.1~2:1。
4.根据权利要求1-3任一项所述的方法,其特征在于,所述方法进一步包括:
步骤(二):
使式(4)所示的4-(2,2-二甲基-4,6-二氧代-1,3-二氧六环-5-基)-3-氧代丁酸乙酯在乙醇中,在酸存在下进行回流反应,得到式(5)所示的3-氧代己二酸二乙酯。
5.根据权利要求1-4任一项所述的方法,其特征在于,步骤(二)所述酸选自5%的浓硫酸,或者无水氯化氢气体。
6.根据权利要求1-5任一项所述的方法,其特征在于,所述方法进一步包括:
步骤(三):
使式(5)所示的3-氧代己二酸二乙酯在冰醋酸中与亚硝酸钠进行亚硝化反应,得到式(6)所示的2-(羟基亚氨基)-3-氧代己二酸二乙酯。
7.根据权利要求1-6任一项所述的方法,其特征在于,所述方法进一步包括:
步骤(四):
使式(6)所示的2-(羟基亚氨基)-3-氧代己二酸二乙酯在适当的溶剂中,经还原反应得到式(7)所示的2-氨基-3-氧代己二酸二乙酯。
8.根据权利要求1-7任一项所述的方法,其特征在于,步骤(四)所述还原反应在10-60℃温度下,在Pd/C存在下通入氢气进行反应,所述溶剂选自无水乙醇。
9.根据权利要求1-8任一项所述的方法,其特征在于,所述方法进一步包括:
步骤(五):
使式(7)所示的2-氨基-3-氧代己二酸二乙酯在2-12mol/L的盐酸中加热回流反应4-24小时,反应结束后,将反应液浓缩至干,接着向浓缩物中加入丙酮进行重结晶,得到式(1)所示的5-氨基乙酰丙酸盐酸盐。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310841671.XA CN116969916A (zh) | 2023-07-11 | 2023-07-11 | 一种制备5-氨基乙酰丙酸盐酸盐的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310841671.XA CN116969916A (zh) | 2023-07-11 | 2023-07-11 | 一种制备5-氨基乙酰丙酸盐酸盐的方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116969916A true CN116969916A (zh) | 2023-10-31 |
Family
ID=88478879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310841671.XA Pending CN116969916A (zh) | 2023-07-11 | 2023-07-11 | 一种制备5-氨基乙酰丙酸盐酸盐的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116969916A (zh) |
-
2023
- 2023-07-11 CN CN202310841671.XA patent/CN116969916A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5380935A (en) | Process for preparing 5-aminolevulinic acid | |
EP2914574B1 (en) | New process | |
EP2921473B1 (en) | 1-cyan-1-(7-methoxyl-1-naphtyl) methanol ester compound and preparation method and use thereof | |
CN116969916A (zh) | 一种制备5-氨基乙酰丙酸盐酸盐的方法 | |
CN113501771A (zh) | 一种n-(2-氨乙基)甘氨酸衍生物的制备方法 | |
CN108947908B (zh) | 具咪唑环的布瓦西坦新中间体及其合成方法和应用 | |
WO2021020998A1 (ru) | Способ получения роксадустата | |
CN107954960B (zh) | 一种1,3-二氢异苯并呋喃类化合物的合成方法 | |
CN108409561B (zh) | 一种5-氨基酮戊酸盐酸盐及中间体的制备方法 | |
CN101857575A (zh) | 2-氨基-5-甲基吡嗪的工业化制备方法 | |
CN112778189A (zh) | (3r,4s)-n-取代基-3-羧酸-4-乙基吡咯烷、中间体及乌帕替尼 | |
CN114105848B (zh) | 一种顺式-d-羟脯氨酸衍生物的制备方法 | |
CN115819221B (zh) | 一种(r)-2-羟甲基丙酸和(s)-2-羟甲基丙酸的制备方法 | |
KR101699990B1 (ko) | 지방산/l-카르니틴 유도체의 제조 방법 | |
CN114181100A (zh) | 一种5-氨基酮戊酸盐酸盐的合成方法 | |
CN113493423A (zh) | 一种免疫调节剂的关键中间体合成方法 | |
CN112321512A (zh) | 一种4,5-二碘-1h-咪唑的合成方法 | |
CN113024624A (zh) | 一种去氧胆酸的合成方法 | |
KR101724409B1 (ko) | 하이브리드 아스코르빈산 유도체 및 그 제조방법 | |
CN118206469A (zh) | 一种3-羟基-4-(三氟甲基)苯甲腈的合成方法 | |
CN104513189B (zh) | 一种奥拉西坦中间体及其制备方法和应用 | |
CN114292240A (zh) | 一种曲格列汀杂质的制备方法 | |
CN115710213A (zh) | 一种顺式手性3-氟-4-羟基哌啶及其衍生物的制备方法 | |
CN116969881A (zh) | 一种吡仑帕奈的合成方法 | |
CN117865832A (zh) | L-谷氨酸-α-叔丁酯的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |